Muhammad Sibte  Hasan Mahmood,Tiyyaba  Furqan,Muaaz  Karim,Sidra Batool,
In silico Analysis of Alkaloids for Therapeutic Use in Treatment of Alzheimer's Disease by Targeting Acetylcholinesterase Enzyme
Neurology and Neurobiology
2021
2613-7828
http://dx.doi.org/10.31487/j.NNB.2021.02.02
https://www.sciencerepository.org/in-silico-analysis-of-alkaloids-for-therapeutic-use-in-treatment_NNB-2021-2-102 
Abstract: Alzheimer’s is a progressive mental deterioration associated with the degeneration of the cognition activities and memory loss. It is considered to be a multifactorial disease. One of the causes of the Alzheimer’s disease is the low concentration of the neurotransmitter named acetylcholine (ACh) at the synaptic cleft. Thus, inhibitor of Acetylcholinesterase (AChE), an enzyme whose function is to degrade the acetylcholine, is proved to be a promising candidate to treat this disease. Among the inhibitors are the natural alkaloids that also have an inhibitory effect on the AChE. In this study we have focused on the simple derivates of beta carbolime (a group of alkaloids) and studied their interaction with AChE via rigid protein-ligand docking approach.Keywords: Beta carbolines, alkaloids, docking, acetylcholinesterase, inhibitor